OLIGO-METASTATIC CANCER

Clinical trials for OLIGO-METASTATIC CANCER explained in plain language.

Never miss a new study

Get alerted when new OLIGO-METASTATIC CANCER trials appear

Sign up with your email to follow new studies for OLIGO-METASTATIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New combo therapy aims to stop limited cancer spread in its tracks

Disease control Not yet recruiting

This study is testing whether combining a precise, high-dose radiation treatment (SBRT) with a new targeted drug (vibecotamab) can better control cancer that has spread to a few sites in the body. It is for adults with EGFR-positive solid tumors that have spread to 5 or fewer loc…

Matched conditions: OLIGO-METASTATIC CANCER

Phase: PHASE3 • Sponsor: Ming-Yuan Chen • Aim: Disease control

Last updated Mar 24, 2026 12:02 UTC

OLIGO-METASTATIC CANCER

Get alerted when new OLIGO-METASTATIC CANCER trials appear

New combo therapy aims to stop limited cancer spread in its tracks